Literature DB >> 19519364

In search of the most suitable lentiviral shRNA system.

Tomas Jan Bos1, Elke De Bruyne, Carlo Heirman, Karin Vanderkerken.   

Abstract

A decade after its discovery, RNA interference has proven to be an instant success both in fundamental research and clinical applications. Lentiviral delivery of shRNAs is one of the most popular approaches to study gene functionalities in both developmental biology and disorders. During the past 10 years, several adaptations and novel techniques have emerged to improve (conditional) transgene expression and to meet researchers' needs. However, due to this magnitude of diversity, it is sometimes difficult to select the most suitable approach for a specific experimental setup. Here, we summarize the different systems and techniques available for every step in the generation of shRNA-bearing lentiviruses. The most crucial point is inevitably the selection of the target sequence itself. A good shRNA design is indispensable and determines almost completely the success of the experiments. In addition, an adequate promoter that drives the shRNA expression has to be chosen depending on its strength, inducibility, tissue-specificity, At this point, the researcher has also to decide whether the expression of the shRNA should be inducible or not. Another point one has to keep in mind is the choice of lentiviral vector in which the silencing cassette will be incorporated; single- or double-copy vectors are available. The last 2 years, shRNA multiplex approaches in which several targets are silenced with one vector have emerged and have shown a lot of potential in complex studies (like HIV-1). Finally, in the last section, we will discuss the possible induction of an immune response by short dsRNA molecules.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19519364     DOI: 10.2174/156652309788488578

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  5 in total

Review 1.  Selective gene silencing by viral delivery of short hairpin RNA.

Authors:  Katja Sliva; Barbara S Schnierle
Journal:  Virol J       Date:  2010-09-21       Impact factor: 4.099

2.  Efficient downregulation of multiple mRNA targets with a single shRNA-expressing lentiviral vector.

Authors:  Stepan P Chumakov; Julia E Kravchenko; Vladimir S Prassolov; Elena I Frolova; Peter M Chumakov
Journal:  Plasmid       Date:  2010-01-11       Impact factor: 3.466

3.  Downregulation of mTOR by lentivirus inhibits prostate cancer cell growth.

Authors:  Yue-Feng Du; Qing-Zhi Long; Ying Shi; Xiao-Gang Liu; Xu-Dong Li; Jin Zeng; Yong-Guang Gong; Xin-Yang Wang; Da-Lin He
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

Review 4.  Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference.

Authors:  Rodolphe Barrangou; Amanda Birmingham; Stefan Wiemann; Roderick L Beijersbergen; Veit Hornung; Anja van Brabant Smith
Journal:  Nucleic Acids Res       Date:  2015-03-23       Impact factor: 16.971

Review 5.  Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape.

Authors:  Martyn K White; Wenhui Hu; Kamel Khalili
Journal:  PLoS Pathog       Date:  2016-12-08       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.